🔎 Trials Near Me

Dachaigh › Lymphoma › New York

Sgrùdaidhean clionaigeach Lymphoma ann an New York

Tha 42 sgrùdaidhean airson Lymphoma a’ lorg phàirtichean aig làraichean ann an New York.

Bailtean ann an New York

Teacsa sgrùdaidh oifigeil (Beurla)

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma

  • Columbia University, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Dàmh 2026 · NCT04234048

A Study of the Efficacy and Safety of Lisocabtagene Maraleucel (Liso-cel) as First-Line Therapy in Adults With Transplant-Ineligible Primary Central Nervous System Lymphoma

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07015242

A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 30 Sult 2026 · NCT07192471

Epco, Zanu, Ritux for R/R FL or MZL

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Sult 2026 · NCT06563596

Study of Ruxolitinib in Relapsed or Refractory T or NK Cell Lymphoma

  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, East White Plains
  • Memorial Sloan Kettering Cancer Center, New York
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 24 Sult 2026 · NCT02974647

Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • agus 1 a bharrachd
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Sult 2026 · NCT04301076

Collection of Tissue Samples for Cancer Research

  • Roswell Park Cancer Institute, Buffalo
A’ fastadhSgrùdadh amharc
2 Months · Gach gnè · Air ùrachadh 16 Sult 2026 · NCT00900198

Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma

  • Cornell, New York
A’ fastadhÌre 1
Aoisean 18 gu 100 · Gach gnè · Air ùrachadh 15 Sult 2026 · NCT05798897

AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.

  • Research Site, New York
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 14 Sult 2026 · NCT06137144

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • Roswell Park Cancer Institute, Buffalo
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • agus 1 a bharrachd
A’ fastadhÌre 1/2
12 Months – 21 Years · Gach gnè · Air ùrachadh 11 Sult 2026 · NCT04870944

A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

  • Stony Brook Univ Cancer Ctr, Stony Brook
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Sult 2026 · NCT06624085

TLN-121 in Relapsed or Refractory Non-Hodgkin Lymphomas

  • Memorial Sloan Kettering Cancer Center, New York
  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Sult 2026 · NCT07082803

A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma

  • Hematology Oncology Associates of Central New York, East Syracuse
  • University of Rochester, Rochester
  • Stony Brook University Hospital Cancer Center, Stony Brook
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 3 Sult 2026 · NCT06084936

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, The Bronx
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05826535

A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma

  • Memorial Sloan Kettering Suffolk- Commack (Limited protocol activities), Commack
  • Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Lùna 2026 · NCT05389293

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

  • New York Medical College, Valhalla
A’ fastadhÌre 1/2
Aoisean 13 gu 90 · Gach gnè · Air ùrachadh 6 Lùna 2026 · NCT06533579

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

  • Roswell Park Comprehensive Cancer Center, Buffalo
A’ fastadhÌre 3
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 4 Lùna 2026 · NCT07188558

DALY II USA/ MB-CART2019.1 for DLBCL

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Iuch 2026 · NCT04792489

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

  • Memorial Sloan Kettering, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 8 Iuch 2026 · NCT07465835

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

  • Call for Information (Investigational Site 0031), New York
A’ fastadhÌre 1/2
6 Months – 17 Years · Gach gnè · Air ùrachadh 6 Iuch 2026 · NCT02332668

CD4CAR for CD4+ Leukemia and Lymphoma

  • Albert Einstein Health Network, New York
A’ fastadhÌre 1
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 24 Ògmh 2026 · NCT03829540

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

  • Dren Investigational Site 1, New York
  • Dren Investigational Site 2, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 17 Ògmh 2026 · NCT05475925

A Study of MB-CART19.1 Cellular Therapy for People With Central Nervous System Lymphoma (CNSL)

  • Memorial Sloan Kettering at Suffolk-Commack (Limited Protocol Activities), Commack
  • Memorial Sloan Kettering at Westchester (Limited Protocol Activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • agus 1 a bharrachd
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Ògmh 2026 · NCT07137494

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

  • Mount Sinai Hospital, New York
  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 1 Ògmh 2026 · NCT05663502

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

  • Columbia University Irving Medical Center, New York
A’ fastadhÌre 2
Aoisean 15 agus nas sine · Gach gnè · Air ùrachadh 27 Cèit 2026 · NCT06954805

A Music Therapy Study for Blood Cancer Survivors With Cognitive Difficulties

  • Memorial Sloan Kettering Cancer Center Suffolk - Commack (All protocol activities), Commack
  • Memorial Sloan Kettering Westchester (All protocol activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All protocol activities), New York
  • agus 1 a bharrachd
A’ fastadhFàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 26 Cèit 2026 · NCT07052916

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park
  • University of Rochester, Rochester
  • Stony Brook University Medical Center, Stony Brook
  • agus 1 a bharrachd
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT01790152

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
A’ fastadhÌre 2
Suas gu aois 26 · Gach gnè · Air ùrachadh 14 Cèit 2026 · NCT07566377

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

  • Roswell Park Comprehensive Cancer Center, Buffalo
  • Mt Sinai, New York
  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 1/2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 16 Gibl 2026 · NCT03328078

Study of CAR-T Therapy in Older Patients

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhSgrùdadh amharc
Aoisean 60 agus nas sine · Gach gnè · Air ùrachadh 7 Gibl 2026 · NCT04300998

Epcoritamab in Patients With Follicular Lymphoma Not Accomplishing a CR With Upfront Chemoimmunotherapy

  • Icahn School of Medicine at Mount Sinai, New York
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Màrt 2026 · NCT06510361

A Study of Mogamulizumab to Prevent Adult T-cell Leukemia/Lymphoma in People With HTLV-1

  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (All protocol activities), Commack
  • Memorial Sloan Kettering Westchester (All protocol activities), Harrison
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
  • agus 1 a bharrachd
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 5 Màrt 2026 · NCT06698003

Longitudinal Sexual and Reproductive Health Study of Women With Breast Cancer and Lymphoma

  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • agus 1 a bharrachd
A’ fastadhSgrùdadh amharc
Aoisean 18 agus nas sine · Banairean · Air ùrachadh 4 Màrt 2026 · NCT01788839

BRAZAN: A Randomized Phase 2 Study of Bendamustine, Rituximab, Cytarabine (AraC) Induction With Zanubrutinib (BRAZAN) Followed by Zanubrutinib/Rituximab +/- Sonrotoclax Maintenance in Treatment-Naïve Mantle Cell Lymphoma

  • Memorial Sloan Kettering Cancer Center, New York
A’ fastadhÌre 2
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 20 Gearr 2026 · NCT06854003

Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders

  • Memorial Sloan Kettering Commack, Commack
  • Memorial Sloan Kettering Westchester, Harrison
  • Memorial Sloan Kettering Cancer Center, New York
  • agus 1 a bharrachd
A’ fastadhSgrùdadh amharcFàilte do shaor-thoilich fhallain
Gach aois · Gach gnè · Air ùrachadh 23 Faoi 2026 · NCT00582621

ctDNA-guided Therapy Optimization in Newly Diagnosed DLBCL

  • Columbia University, New York
A’ fastadh
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 23 Faoi 2026 · NCT06693830

Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial

  • Noyes Memorial Hospital/Myers Cancer Center, Dansville
  • Northwell Health/Center for Advanced Medicine, Lake Success
  • Highland Hospital, Rochester
  • agus 3 a bharrachd
A’ fastadhÌre 3Fàilte do shaor-thoilich fhallain
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 13 Faoi 2026 · NCT05006482

CD5-deleted Chimeric Antigen Receptor Cells (Senza5 CART5) for T Cell Non-Hodgkin Lymphoma (NHL)

  • Columbia University Irving Medical Center, New York
A’ fastadhÌre 1
Aoisean 18 agus nas sine · Gach gnè · Air ùrachadh 10 Samh 2025 · NCT06420089

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.